Amgen Disagrees With FDA Proposal To Withdraw TAVNEOS From U.S. Market; Submitted Data And Analyses To FDA To Request Hearing On TAVNEOS

https://www.amgen.com/newsroom/company-statements/amgen-statement-on-fda-data-submission-for-tavneos?_gl=1*p4mfe*_up*MQ..*_ga*MjAxMjQ2Mjc4My4xNzg0ODk1MTYx*_ga_CBMSV0J9VL*czE3ODQ4OTUxNjEkbzEkZzEkdDE3ODQ4OTUxODMkajM4JGwwJGgw